stocks logo

DRTS Financial Analysis

Alpha Tau Medical Ltd
$
2.520
0.000(0.000%)

DRTS Financial Analysis

FY2022Q2FY2022Q1FY2021Q2FY2021Q1
Net Cash Flow from Operating Activities
-8.74M
290.49%
-6.59M
110.52%
-2.24M
-3.13M
Funds from Operations
-6.23M
106.39%
-6.58M
167.53%
-3.02M
-2.46M
Change in Working Capital
-2.51M
-422.05%
-1,000
-99.85%
780.00K
-667.00K
Net Cash Flow from Investing Activities
-92.38M
-4956.83%
-298.00K
-51.07%
1.90M
-609.00K
Capital Expenditures - Net
377.00K
-36.96%
298.00K
-51.07%
598.00K
609.00K
Net Cash Flow from Financing Activities
14.82M
73975.00%
81.99M
8198400.00%
20.00K
1,000
Stock - Total - Issuance/(Retirement) - Net
1.91M
9435.00%
1.35M
134900.00%
20.00K
1,000
Net Change in Cash
-86.55M
54675.32%
75.05M
-1845.44%
-158.00K
-4.30M
Free Cash Flow
-9.12M
221.47%
-6.88M
84.19%
-2.84M
-3.74M

DRTS FAQs

What is DRTS's PE Ratio in 2025/4/4?

DRTS's PE ratio in April 4, 2025 is -5.55. This indicates the price investors are willing to pay for $1 of earnings.

What is DRTS's PS Ratio in 2025/4/4?

What is DRTS's Dividend Yield in 2024/Q3?

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

Is DRTS earnings result positive or negative?How should I trade on DRTS earnings?